Arterial wave reflection during antihypertensive therapy with barnidipine: A 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension

Clinical Therapeutics

Volumn 31, Issue 12, 2009, Pages 2873-2885

  Palombo, Carlo ^a   Malshi, Emona ^a   Morizzo, Carmela ^a   Rakebrandt, Frank ^b   Corretti, Valentina ^a   Santini, Francesca ^a   Fraser, Alan G ^b   Kozakova, Michaela ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

arterial stiffness; arterial wave reflection; barnidipine; cardiovascular ultrasound; LV performance; wave intensity analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; MEPIRODIPINE;

ADULT; ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; MALE; OPEN STUDY; PATIENT COMPLIANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; YOUNG MODULUS;

AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VENTRICULAR FUNCTION, LEFT;

EID: 74549220989     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.12.011     Document Type: Article

References (41)

1. Tumbull F., and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomized trials. Lancet 362 (2003) 1527-1535
2. Safar M.E., Blacher J., Pannier B., et al. Central pulse pressure and mortality in end-stage renal failure. Hypertension 39 (2002) 735-738
3. Kingwell B.A., Waddell T.K., Medley T.L., et al. Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol. 40 (2002) 773-779
4. Roman M.J., Devereux R.B., Kizer J.R., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 50 (2007) 197-203
5. Morgan T., Lauri J., Bertram D., and Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 17 (2004) 118-123
6. Williams B., Lacy P.S., Thom S.M., et al., CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcome: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113 (2006) 1213-1225
7. Westerhof B.E., Guelen I., Westerhof N., et al. Quantification of wave reflection in the human aorta from pressure alone: A proof of principle. Hypertension 48 (2006) 595-601
8. Payne R.A., and Webb D.J. Peripheral augmentation index: Shouldering the central pressure load. Hypertension 51 (2008) 37-38
9. Nichols W.W. Clinical measurements of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 18 (2005) 3S-10S
10. Nichols W.W., and Singh B.M. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 17 (2002) 543-551
11. Davies J.I., and Struthers A.D. Pulse wave analysis and pulse wave velocity: A critical review of their strengths and weaknesses. J Hypertens 21 (2003) 463-472
12. Parker K.H., and Jones C.J.H. Forward and backward running waves in the arteries: Analysis using the method of characteristics. J Biomech Eng. 112 (1990) 322-326
13. Bleasdale R.A., Parker K.H., and Jones C.J. Chasing the wave. Unfashionable but important new concepts in arterial wave travel. Am J Physiol Heart Circ Physiol. 284 (2003) H1879-H1885
14. Jones C.J., and Sugawara M. "Wavefronts" in the aortaimplications for the mechanisms of left ventricular ejection and aortic valve closure. Cardiovasc Res. 27 (1993) 1902-1905
15. Jones C.J., Sugawara M., Kondoh Y., et al. Compression and expansion wavefront travel in canine ascending aortic flow: Wave intensity analysis. Heart Vessels. 16 (2002) 91-98
16. Ohte N., Narita H., Sugawara M., et al. Clinical usefulness of carotid arterial wave intensity in assessing left ventricular systolic and early diastolic performance. Heart Vessels 18 (2003) 107-111
17. Niki K., Sugawara M., Chang D., et al. A new noninvasive measurement system for wave intensity: Evaluation of carotid arterial wave intensity and reproducibility. Heart Vessels 17 (2002) 12-21
18. Sugawara M., Niki K., Furuhata H., et al. Relationship between the pressure and diameter of the carotid artery in humans. Heart Vessels 15 (2000) 49-51
19. Fujimoto S., Mizuno R., Saito Y., and Nakamura S. Clinical application of wave intensity for the treatment of essential hypertension. Heart Vessels 19 (2004) 19-22
20. Malhotra H.S., and Plosker G.L. Barnidipine. Drugs. 61 (2001) 989-996
21. discussion. Malhotra H.S., and Plosker G.L. Barnidipine. Drugs. 61 (2001) 997-998
22. Liau C.S. Barnidipine: A new calcium channel blocker for hypertension treatment. Expert Rev Cardiovasc Ther. 3 (2005) 207-213
23. Mancia G., De Backer G., Dominiczak A., Management of Arterial Hypertension of the European Society of Hypertension, and European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [published correction appears in J Hypertens. 2007;25:1749]. J Hypertens. 25 (2007) 1105-1187
24. Lang R.M., Bierig M., Devereux R.B., et al., American Society of Echocardiography's Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 7 (2006) 79-108
25. de Simone G., Devereux R.B., Koren M.J., et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 93 (1996) 259-265
26. Devereux R.B., Roman M.J., de Simone G., et al. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: The Strong Heart Study. Circulation. 96 (1997) 1416-1423
27. de Simone G., Devereux R.B., Kimball T.R., et al. Interaction between body size and cardiac workload: Influence on left ventricular mass during body growth and adulthood. Hypertension. 31 (1998) 1077-1082
28. Vinereanu D., Florescu N., Sculthorpe N., et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 88 (2001) 53-58
29. Swampillai J., Rakebrandt F., Morris K., et al. Acute effects of caffeine and tobacco on arterial function and wave travel. Eur J Clin Invest. 36 (2006) 844-849
30. Laurent S., Cockcroft J., Van Bortel L., et al., European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 27 (2006) 2588-2605
31. Armitage P., and Berry G. Statistical Methods in Medical Research. 2nd ed. (1987), Blackwell Science, Boston, Mass 186-213
32. Rakebrandt F., Palombo C., Swampillai J., et al. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound: Rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol. 35 (2009) 266-277
33. Sugawara M., Niki K., Ohte N., et al. Clinical usefulness of wave intensity analysis. Med Biol Eng Comput. 47 (2009) 197-206
34. Curtis S.L., Zambanini A., Mayet J., et al. Reduced systolic wave generation and increased peripheral wave reflections in chronic heart failure. Am J Physiol Heart Circ Physiol. 293 (2007) H557-H562
35. Hart W., Holwerda N.J., and Dutch Barnidipine Multicenter Study Group. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: A multicenter, doubleblind, placebo-controlled, doseranging study. Dutch Barnidipine Multicenter Study Group. Cardiovasc Drugs Ther. 11 (1997) 637-643
36. Jiang X.J., O'Rourke M.F., Zhang Y.Q., et al. Superior effect of the angiotensinconverting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens. 25 (2007) 1095-1099
37. Swillens A., and Segers P. Assessment of arterial pressure wave reflection: Methodological considerations. Artery Res. 2 (2008) 122-131
38. Nichols W.W., and Edwards D.G. Arterial elastance and wave reflection augmentation of systolic blood pressure: Deleterious effects and implications for therapy. J Cardiovasc Pharmacol Ther. 6 (2001) 5-21
39. Nürnberger J., Keflioglu-Scheiber A., Opazo Saez A.M., et al. Augmentation index is associated with cardiovascular risk. J Hypertens. 20 (2002) 2407-2412
40. Kelly R.P., Milasseau S.C., Ritter J.M., and Chowienczyk P.J. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 37 (2001) 1429-1433
41. Mitchell G.F., Parise H., Benjamin E.J., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart Study. Circulation. 43 (2004) 1239-1245